Insider Transactions in Q3 2023 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
6,898
-3.77%
|
$344,900
$50.17 P/Share
|
|
Sep 28
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
6,898
+3.63%
|
$6,898
$1.87 P/Share
|
|
Sep 27
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
18,102
-3.18%
|
$886,998
$49.76 P/Share
|
|
Sep 27
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
18,102
+8.53%
|
$18,102
$1.87 P/Share
|
|
Aug 25
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
10,000
-5.37%
|
$500,000
$50.16 P/Share
|
|
Aug 25
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.1%
|
$10,000
$1.87 P/Share
|
|
Aug 24
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
15,000
-7.85%
|
$735,000
$49.57 P/Share
|
|
Aug 24
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.28%
|
$15,000
$1.87 P/Share
|